Learning Objectives: On successful completion of this activity, participants should be able to (1) describe the clinical state of oligometastatic disease along the natural history of prostate cancer; (2) discuss the outcome results of the various clinical trials on metastasis-directed therapy of oligometastatic disease in prostate cancer; and (3) recognize the gaps in knowledge and needed additional areas of research relevant to oligometastatic prostate cancer.